Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,354.48
+338.42(+0.68%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Rapid Micro Biosystems, Inc. (RPID)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

0.8900

-0.0862

(-8.83%)

At close: 04:00PM EDT

0.9100

+0.02

(+2.25%)

After hours:

07:45PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	38.09M
Enterprise value	-46.62M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.70
Price/book (mrq)	0.32
Enterprise value/revenue	-2.07
Enterprise value/EBITDA	0.87

Trading information

Stock price history

Beta (5Y monthly)	1.26
52-week change ³	19.28%
S&P500 52-week change ³	22.38%
52-week high ³	1.1900
52-week low ³	0.7400
50-day moving average ³	0.9694
200-day moving average ³	0.9914

Share statistics

Avg vol (3-month) ³	41k
Avg vol (10-day) ³	28.85k
Shares outstanding ⁵	37.48M
Implied shares outstanding ⁶	42.79M
Float ⁸	9.13M
% held by insiders ¹	12.29%
% held by institutions ¹	64.97%
Shares short (15 Apr 2024) ⁴	60.88k
Short ratio (15 Apr 2024) ⁴	1.65
Short % of float (15 Apr 2024) ⁴	0.31%
Short % of shares outstanding (15 Apr 2024) ⁴	0.14%
Shares short (prior month 15 Mar 2024) ⁴	80.34k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-232.99%
Operating margin (ttm)	-192.33%

Management effectiveness

Return on assets (ttm)	-21.16%
Return on equity (ttm)	-37.19%

Income statement

Revenue (ttm)	22.52M
Revenue per share (ttm)	0.52
Quarterly revenue growth (yoy)	44.90%
Gross profit (ttm)	N/A
EBITDA	-53.76M
Net income avi to common (ttm)	-52.47M
Diluted EPS (ttm)	-1.2200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	92.72M
Total cash per share (mrq)	2.18
Total debt (mrq)	7.35M
Total debt/equity (mrq)	6.23%
Current ratio (mrq)	6.34
Book value per share (mrq)	2.78

Cash flow statement

Operating cash flow (ttm)	-45.08M
Levered free cash flow (ttm)	-28.59M